SURGICEL Family of Absorbable Hemostats: payments to doctors
Payments that named SURGICEL Family of Absorbable Hemostats as the associated device or medical supply, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $636K
- Providers
- 1,453
- Transactions
- 1,932
- Average per transaction
- $329
The per-transaction average — $329 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 1,453 providers the average total is $438, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Medical Device Business Services, Inc. | $448,962 | 70.6% |
| Johnson & Johnson | $175,563 | 27.6% |
| Johnson & Johnson Medical Devices & Diagnostics Group - Latin America, L.L.C. | $9,120 | 1.4% |
| Johnson And Johnson International | $2,174 | 0.3% |